Federation des caisses Desjardins du Quebec’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,315	Closed	-$268K	–	2307
2020 Q1	$268K	Sell	6,315 -1,618	-20%	-$74.2K	﹤0.01%	787
2019 Q4	$360K	Hold	7,933	–	–	0.01%	865
2019 Q3	$363K	Buy	7,933 +3,609	+83%	+$203K	0.01%	855
2019 Q2	$253K	Buy	+4,324	New	+$223K	﹤0.01%	964
2017 Q4	–	Sell	-25	Closed	-$638	–	2201
2017 Q3	$638	Buy	+25	New	+$573	﹤0.01%	2015

Other funds holding ARNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ARNA Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2020, closing a stake of 6,315 shares — an estimated $268K sold.

Federation des caisses Desjardins du Quebec first reported a position in ARNA in Q3 2017 and held it in 5 quarters. The position peaked at $363K in Q3 2019. 247 funds tracked by Wall St. Rank hold ARNA as of Q2 2020.

Federation des caisses Desjardins du Quebec reported no remaining Arena Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 6,315 Arena Pharmaceuticals Inc shares in Q2 2020, an estimated $268K.
Federation des caisses Desjardins du Quebec first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 5 quarters.
Federation des caisses Desjardins du Quebec's Arena Pharmaceuticals Inc position peaked at $363K in Q3 2019.
247 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.